By this summer, Pfizer plans to deploy tablet PCs to 5,000 primary care, oncology, established products and specialty care reps detailing about 22 products.
B2B media firm Lebhar-Friedman sold the journals division of Dowden Health Media to Quadrant HealthCom in a move it said was designed to decrease reliance on advertising-based businesses.
Adrienne Fanti and Tracy Peterson take a look back at the extraordinary lives and achievements of the Medical Advertising Hall of Fame’s three newest members
The list of top 50 CV products to emerge from “the Aughts” looks set for a shakeup entering “the Tens.” Marc Iskowitz examines threats and opportunities expected from generic Lipitor and emerging CETP inhibitors, as well as market dynamics within the anti-platelet and anti-hypertensive segments
How come vaccine manufacturers take so much heat about flu vaccines? They are blamed for using outdated technologies, delay in shipments and contaminated batches. They are even targeted by fear mongers without a shred of evidence to show harm.
The pharma industry looks to the next decade with trepidation. Growth in many sectors is flat. Generic expiries loom. Trust in the industry is at rock bottom.
Loading...
MM+M Transform: The Patient, Provider and Payer Engagement Matrix